Antibody GD3G7 selected against embryonic glycosaminoglycans defines chondroitin sulfate-E domains highly up-regulated in ovarian cancer and involved in vascular endothelial growth factor binding

American Journal of Pathology

Volumn 171, Issue 4, 2007, Pages 1324-1333

  Ten Dam, Gerdy B ^a   Van De Westerlo, Els M A ^a   Purushothaman, Anurag ^c   Stan, Radu V ^d   Bulten, Johan ^b   Sweep, Fred C G J ^b   Massuger, Leon F ^b   Sugahara, Kazuyuki ^c,e   Van Kuppevelt, Toin H ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c KOBE PHARMACEUTICAL UNIVERSITY   (Japan)

^d DARTMOUTH MEDICAL SCHOOL   (United States)

^e HOKKAIDO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; CHONDROITIN SULFATE E; EPITOPE; GD3G7 ANTIBODY; GLYCOSAMINOGLYCAN; MONOCLONAL ANTIBODY; PROTEIN SUBUNIT; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYSTADENOMA; EMBRYO; EMBRYO CELL; GENE EXPRESSION; HUMAN; HUMAN TISSUE; NONHUMAN; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN DOMAIN; RAT; UPREGULATION;

EID: 35348865447     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2007.070111     Document Type: Article

References (46)

1. Sugahara K, Mikami T, Uyama T, Mizuguchi S, Nomura K, Kitagawa H: Recent advances in the structural biology of chondroitin sulfate and dermatan sulfate. Curr Opin Struct Biol 2003, 13:612-620
2. Nash MA, Deavers MT, Freedman RS: The expression of decorin in human ovarian tumors. Clin Cancer Res 2002, 8:1754-1760
3. Ladányi A, Gallai M, Paku S, Nagy JO, Dudas J, Timar J, Kovalszky I: Expression of a decorin-like molecule in human melanoma. Pathol Oncol Res 2001, 7:260-266
4. Theocharis AD: Human colon adenocarcinoma is associated with specific post-translational modifications of versican and decorin. Biochim Biophys Acta 2002, 1588:165-172
5. Voutilainen K, Anttila M, Sillanpaa S, Tammi R, Tammi M, Saarikoski S, Kosma VM: Versican in epithelial ovarian cancer: relation to hyaluronan, clinicopathologic factors and prognosis. Int J Cancer 2003, 107:359-364
6. Theocharis AD, Tsara ME, Papageorgacopoulou N, Karavias DD, Theocharis DA: Pancreatic carcinoma is characterized by elevated content of hyaluronan and chondroitin sulfate with altered disaccharide composition. Biochim Biophys Acta 2000, 1502:201-206
7. Theocharis AD, Vynios DH, Papageorgakopoulou N, Skandalis SS, Theocharis DA: Altered content composition and structure of glycosaminoglycans and proteoglycans in gastric carcinoma. Int J Biochem Cell Biol 2003, 35:376-390
8. Denholm EM, Lin YQ, Silver PJ: Anti-tumor activities of chondroitinase AC and chondroitinase B: inhibition of angiogenesis, proliferation and invasion. Eur J Pharmacol 2001, 416:213-221
9. Deepa SS, Umehara Y, Higashiyama S, Itoh N, Sugahara K: Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues. J Biol Chem 2002, 277:43707-43716
10. Hikino M, Mikami T, Faissner A, Vilela-Silva AC, Pavao MS, Sugahara K: Oversulfated dermatan sulfate exhibits neurite outgrowth-promoting activity toward embryonic mouse hippocampal neurons: implications of dermatan sulfate in neuritogenesis in the brain. J Biol Chem 2003, 278:43744-43754
11. Kinoshita A, Yamada S, Haslam SM, Morris HR, Dell A, Sugahara K: Isolation and structural determination of novel sulfated hexasaccharides from squid cartilage chondroitin sulfate E that exhibits neuroculatory activities. Biochemistry 2001, 40:12654-12665
12. Nandini CD, Mikami T, Ohta M, ltoh N, Akiyama-Nambu F, Sugahara K: Structural and functional characterization of oversulfated chondroitin sulfate/dermatan sulfate hybrid chains from the notochord of hagfish. Neuritogenic and binding activities for growth factors and neurotrophic factors. J Biol Chem 2004, 279:50799-50809
13. Kawashima H, Atarashi K, Hirose M, Hirose J, Yamada S, Sugahara K, Miyasaka M: Oversulfated chondroitin/dermatan sulfates containing GlcAbeta1/IdoAalpha1-3GalNAc(4,6-O-disulfate) interact with L-and P-selectin and chemokines. J Biol Chem 2002, 277:12921-12930
14. Kusche-Gullberg M, Kjellen L: Sulfotransferases in glycosaminoglycan biosynthesis. Curr Opin Struct Biol 2003, 13:605-611
15. Nandini CD, Sugahara K: Role of the sulfation pattern of chondroitin sulfate in its biological activities and in the binding of growth factors. Adv Pharmacol 2006, 53:253-279
16. van de Lest CH, Versteeg EM, Veerkamp JH, van Kuppevelt TH: Quantification and characterization of glycosaminoglycans at the nanogram level by a combined azure A-silver staining in agarose gels. Anal Biochem 1994, 221:356-361
17. Nissim A, Hoogenboom HR, Tomlinson IM, Flynn G, Midgley C, Lane D, Winter G: Antibody fragments from a 'single pot' phage display library as immunochemical reagents. EMBO J 1994, 13:692-698
18. Jenniskens GJ, Oosterhof A, Brandwijk R, Veerkamp JH, van Kuppevelt TH: Heparan sulfate heterogeneity in skeletal muscle basal lamina: demonstration by phage display-derived antibodies. J Neurosci 2000, 20:4099-4111
19. van Kuppevelt TH, Dennissen MA, van Venrooij WJ, Hoet RM, Veerkamp JH: Generation and application of type-specific anti-heparan sulfate antibodies using phage display technology. Further evidence for heparan sulfate heterogeneity in the kidney. J Biol Chem 1998, 273:12960-12966
20. ten Dam GB, Kurup S, van de Westerlo EM, Versteeg EM, Lindahl U, Spillmann D, van Kuppevelt TH: 3-O-Sulfated oligosaccharide structures are recognized by anti-heparan sulfate antibody HS4C3. J Biol Chem 2006, 281:4654-4662
21. Dennissen MA, Jenniskens GJ, Pieffers M, Versteeg EM, Petitou M, Veerkamp JH, van Kuppevelt TH: Large, tissue-regulated domain diversity of heparan sulfates demonstrated by phage display antibodies. J Biol Chem 2002, 277:10982-10986
22. ten Dam GB, Hafmans T, Veerkamp JH, van Kuppevelt TH: Differential expression of heparan sulfate domains in rat spleen. J Histochem Cytochem 2003, 51:727-739
23. van Niekerk CC, Jap PH, Ramaekers FC, van de MF, Poels LG: Immunohistochemical demonstration of keratin 7 in routinely fixed paraffin-embedded human tissues. J Pathol 1991, 165:145-152
24. Nillesen ST, Geutjes PJ, Wismans R, Schalkwijk J, Daamen WF, van Kuppevelt TH: Increased angiogenesis and blood vessel maturation in acellular collagen-heparin scaffolds containing both FGF2 and VEGF. Biomaterials 2007, 28:1123-1131
25. Kinoshita A, Yamada S, Haslam SM, Morris HR, Dell A, Sugahara K: Novel tetrasaccharides isolated from squid cartilage chondroitin sulfate E contain unusual sulfated disaccharide units GloA(3-O-sulfate)beta1-3GalNAc(6-O-sulfate) or GlcA(3-O-sulfate)beta1-3GalNAc. J Biol Chem 1997, 272:19656-19665
26. Ueoka C, Nadanaka S, Seno N, Khoo KH, Sugahara K: Structural determination of novel tetra- and hexasaccharide sequences isolated from chondroitin sulfate H (oversulfated dermatan sulfate) of hagfish notochord. Glyooconj J 1999, 16:291-305
27. Nandini CD, Itoh N, Sugahara K: Novel 70 kDa chondroitin sulfate/dermatan sulfate hybrid chains with a unique heterogenous sulfation pattern from shark skin, which exhibit neuritogenic activity and binding activities for growth factors and neurotrophic factors. J Biol Chem 2005, 280:4058-4069
28. Purushothaman A, Fukuda J, Mizumoto S, ten Dam GB, van Kuppevelt TH, Kitagawa H, Mikami T, Sugahara K: Functions of chondroitin sulfate/dermatan sulfate chains in brain development. Critical roles of E and iE disaccharide units recognized by a single chain antibody GD3G7. J Biol Chem 2007, 282:19442-19452
29. Stan RV, Kubitza M, Palade GE: PV-1 is a component of the fenestral and stomatal diaphragms in fenestrated endothelia. Proc Natl Acad Sci USA 1999, 96:13203-13207
30. Stan RV, Ghitescu L, Jacobson BS, Palade GE: Isolation, cloning, and localization of rat PV-1, a novel endothelial caveolar protein. J Cell Biol 1999, 145:1189-1198
31. Pannabecker TL, Dantzler WH: Three-dimensional architecture of inner medullary vasa recta. Am J Physiol 2006, 290:F1355-F1366
32. Jayson GC, Lyon M, Paraskeva C, Turnbull JE, Deakin JA, Gallagher JT: Heparan sulfate undergoes specific structural changes during the progression from human colon adenoma to carcinoma in vitro. J Biol Chem 1998, 273:51-57
33. Molist A, Romaris M, Lindahl U, Villena J, Touab M, Bassols A: Changes in glycosaminoglycan structure and composition of the main heparan sulphate proteoglycan from human colon carcinoma cells (perlecan) during cell differentiation. Eur J Biochem 1998, 254:371-377
34. Safaiyan F, Lindahl U, Salmivirta M: Selective reduction of 6-O-sulfation in heparan sulfate from transformed mammary epithelial cells. Eur J Biochem 1998, 252:576-582
35. Smetsers TF, van de Westerlo EM, ten Dam GB, Clarijs R, Versteeg EM, van Geloof WL, Veerkamp JH, van Muijen GN, van Kuppevelt TH: Localization and characterization of melanoma-associated glycosaminoglycans: differential expression of chondroitin and heparan sulfate epitopes in melanoma. Cancer Res 2003, 63:2965-2970
36. Smetsers TF, van de Westerlo EM, ten Dam GB, Overes IM, Schalkwijk J, van Muijen GN, van Kuppevelt TH: Human single-chain antibodies reactive with native chondroitin sulfate detect chondroitin sulfate alterations in melanoma and psoriasis. J Invest Dermatol 2004, 122:707-716
37. ten Dam GB, van de Westerlo EM, Smetsers TF, Willemse M, van Muijen GN, Merry CL, Gallagher JT, Kim YS, van Kuppevelt TH: Detection of 2-O-sulfated iduronate and N-acetylglucosamine units in heparan sulfate by an antibody selected against acharan sulfate (IdoA2S-GlcNAc)n. J Biol Chem 2004, 279:38346-38352
38. Pothacharoen P, Siriaunkgul S, Ong-Chai S, Supabandhu J, Kumja P, Wanaphirak C, Sugahara K, Hardingham T, Kongtawelert P: Raised serum chondroitin sulfate epitope level in ovarian epithelial cancer. J Biochem (Tokyo) 2006, 140:517-524
39. Hallmann R, Horn N, Selg M, Wendler O, Pausch F, Sorokin LM: Expression and function of laminins in the embryonic and mature vasculature. Physiol Rev 2005, 85:979-1000
40. Olsson AK, Dimberg A, Kreuger J, Claesson-Welsh L: VEGF receptor signaling - in control of vascular function. Nat Rev Mol Cell Biol 2006, 7:359-371
41. Cross MJ, Claesson-Welsh L: FGF and VEGF function in angiogenesis: signalling pathways, biological responses and therapeutic inhibition. Trends Pharmacol Sci 2001, 22:201-207
42. Kamba T, Tam BY, Hashizume H, Haskell A, Sennino B, Mancuso MR, Norberg SM, O'Brien SM, Davis RB, Gowen LC, Anderson KD, Thurston G, Joho S, Springer ML, Kuo CJ, McDonald DM: VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature. Am J Physiol 2006, 290:H560-H576
43. Robinson CJ, Mulloy B, Gallagher JT, Stringer SE: VEGF165-binding sites within heparan sulfate encompass two highly sulfated domains and can be liberated by K5 lyase. J Biol Chem 2006, 281:1731-1740
44. Shintani Y, Takashima S, Asano Y, Kato H, Liao Y, Yamazaki S, Tsukamoto O, Seguchi O, Yamamoto H, Fukushima T, Sugahara K, Kitakaze M, Hori M: Glycosaminoglycan modification of neuropilin-1 modulates VEGFR2 signaling. EMBO J 2006, 25:3045-3055
45. Ito Y, Hikino M, Yajima Y, Mikami T, Sirko S, von Holst A, Faissner A, Fukui S, Sugahara K: Structural characterization of the epitopes of the monoclonal antibodies 473HD, CS-56, and MO-225 specific for chondroitin sulfate D-type using the oligosaccharide library. Glycobiology 2005, 15:593-603
46. Bao X, Pavao MS, Dos Santos JC, Sugahara K: A functional dermatan sulfate epitope containing iduronate(2-O-sulfate)alpha1-3GalNAc(6-O-sulfate) disaccharide in the mouse brain: demonstration using a novel monoclonal antibody raised against dermatan sulfate of ascidian Ascidia nigra. J Biol Chem 2005, 280:23184-23193